For the latest ecancer COVID-19 resources, click on this link

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

Nottingham University, UK

ESMO 33

12 - 16 Sep 2008

Published: 3 Dec 2008

Views: 17052

Rating:

Save

Prof. Poulam Patel

Extended, escalated dose chemo shows no survival benefit in advanced melanoma.

Categories:
Melanoma & skin

Related Videos

CheckMate067 outcomes: Nivolumab plus ipilimumab in advanced melanoma

Dr Jedd Wolchok - Memorial Sloan Kettering Center, New York, USA

CheckMate067 outcomes: Nivolumab plus ipilimumab in advanced melanoma ( Dr Jedd Wolchok - Memorial Sloan Kettering Center, New York, USA )

LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and con...

Dr Ana Arance - Hospital Clínic de Barcelona, Barcelona, Spain

LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and confirmed progression on a PD-1 or PD-L1 inhibitor ( Dr Ana Arance - Hospital Clínic de Barcelona, Barcelona, Spain )

RELATIVITY-047: Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-lin...

Dr Evan Jacob Lipson - Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, ...

RELATIVITY-047: Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma ( Dr Evan Jacob Lipson - Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )

Phase III randomised trial comparing tebentafusp with investigator’s choice in f...

Dr Jessica Hassel - University Hospital Heidelberg, Heidelberg, Germany

Phase III randomised trial comparing tebentafusp with investigator’s choice in first-line metastatic uveal melanoma ( Dr Jessica Hassel - University Hospital Heidelberg, Heidelberg, Germany )

Adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in p...

Prof Georgina Long - University of Sydney, Sydney, Australia

Adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with resected stage IIIB-D/IV melanoma ( Prof Georgina Long - University of Sydney, Sydney, Australia )

Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small ...

Dr Erminia Massarelli - City of Hope, Duarte, USA

Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small cell lung cancer ( Dr Erminia Massarelli - City of Hope, Duarte, USA )

Advances and challenges in treating melanoma and breast cancer in Romania

Dr Daniela Zob - Institute of Oncology, Bucharest, Romania

Advances and challenges in treating melanoma and breast cancer in Romania ( Dr Daniela Zob - Institute of Oncology, Bucharest, Romania )

Venetoclax combined with AML induction/consolidation therapy with FLAG-IDA in ne...

Dr Curtis Lachowiez - University of Texas MD Anderson Cancer Center, USA

Venetoclax combined with AML induction/consolidation therapy with FLAG-IDA in newly diagnosed or R/R AML ( Dr Curtis Lachowiez - University of Texas MD Anderson Cancer Center, USA )

Updates in geriatric medical oncology from SIOG meeting

Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zu...

Updates in geriatric medical oncology from SIOG meeting ( Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico )

More from ecancer